Neuren Pharmaceuticals Limited
NURPF
Other OTC14.28
USD
- -
- -
Total Valuation
Neuren Pharmaceuticals Limited carries a market capitalization of 1.81B, placing it among publicly traded companies globally.
| Market Cap | 1.81B |
| Enterprise Value | N/A |
Stock Price Statistics
Neuren Pharmaceuticals Limited's stock has gained approximately 20.78849% over the past 52 weeks. The 50-day moving average sits at 15.28, while the 200-day moving average is 11.48.
| Beta (5Y) | N/A |
| 52-Week Price Change | 20.78849% |
| 50-Day Moving Average | 15.28 |
| 200-Day Moving Average | 11.48 |
| Average Volume (20 Days) | N/A |
Stock Splits
Neuren Pharmaceuticals Limited's most recent stock split took place on November 21, 2017 with a 20:1 split ratio.
| Last Split Date | 11/21/2017 |
| Split Ratio | 20:1 |